出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2012/10/19 00:54:54」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Proposal for a new nomenclature of disease-modifying antirheumatic drugs.
  • Smolen JS, van der Heijde D, Machold KP, Aletaha D, Landewé R.SourceDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, , Vienna , Austria.
  • Annals of the rheumatic diseases.Ann Rheum Dis.2014 Jan 1;73(1):3-5. doi: 10.1136/annrheumdis-2013-204317. Epub 2013 Sep 26.
  • In light of the recent emergence of new therapeutics for rheumatoid arthritis, such as kinase inhibitors and biosimilars, a new nomenclature for disease-modifying antirheumatic drugs (DMARDs), which are currently often classified as synthetic (or chemical) DMARDs (sDMARDS) and biological DMARDs (bDM
  • PMID 24072562
  • Drug-induced agranulocytosis in the Berlin case-control surveillance study.
  • Huber M, Andersohn F, Bronder E, Klimpel A, Thomae M, Konzen C, Meyer O, Salama A, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, Kreutz R, Garbe E.SourceInstitute of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • European journal of clinical pharmacology.Eur J Clin Pharmacol.2013 Dec 3. [Epub ahead of print]
  • PURPOSE: Drug-induced agranulocytosis (DIAG) is a rare but serious adverse drug reaction. The Berlin Case-Control Surveillance Study (FAKOS) aimed to identify pharmaceuticals with an increased risk for this condition.METHODS: Adult patients with acute non-chemotherapy-induced agranulocytosis, develo
  • PMID 24297345
  • Treatment of refractory chronic urticaria: current and future therapeutic options.
  • Asero R, Tedeschi A, Cugno M.SourceAmbulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, Milan, Italy,
  • American journal of clinical dermatology.Am J Clin Dermatol.2013 Dec;14(6):481-8. doi: 10.1007/s40257-013-0047-3.
  • Chronic urticaria is a distressing disease that affects up to 1 % of the general population at a time point in life and may severely worsen the quality of life. First-line treatment has been based on antihistamines, and presently relies on the use of non-sedating, second-generation antihistamines;
  • PMID 24085572


  • Clinical and histopathological presentation of pustular psoriasis in an HLA-B27-positive Caucasian with reactive arthritis
  • Nakano Toshiaki,Eto Hikaru
  • The Kitasato medical journal 41(1), 97-102, 2011-03
  • NAID 40018724987
  • 症例 劇症1型糖尿病を発症したサラゾスルファピリジンによる薬剤性過敏症症候群の1例
  • 佐藤 かすみ,末次 靖子,水口 正人 [他]
  • 皮膚科の臨床 52(12), 1851-1854, 2010-11
  • NAID 40017371177


Before taking sulfasalazine, tell your doctor if you are allergic to sulfasalazine, sulfapyridine, aspirin, choline magnesium trisalicylate (Triosal, Trilisate), choline salicylate (Arthropan), mesalamine (Asacol, Pentasa ...
Sulfasalazine official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. ... Drug Abuse and Dependence None reported. Overdosage There is evidence that ...





  [★] サラゾスルファピリジン



スルファサラジン sulfasalazine (欧州)sulphasalazine
Azulfidineアザスルファンアザルフィジンサフィルジンサラゾピリン Salazopyrineスラマソアレジン